Neogenex
Country not established
- Devices
- 20
What Neogenex makes
Neogenex produces primary and continuous cell cultures derived from human, monkey, rabbit, and other animal sources, including primary monkey kidney, MRC-5, A549, MDCK, and VERO cells. The company also manufactures rapid diagnostic tests for influenza B antigen and cytomegalovirus (CMV) early antigen detection.
These products are regulated under FDA Class I and Class II device classifications, with some requiring 510(k) clearance. The cell cultures and diagnostic tests are listed in the FDA’s 510(k) registry, and the company operates from the United States.
Catalogue
Search and filter all 20 devicesFrequently asked questions
How many devices does Neogenex have in the registry?
The registry currently lists 20 devices for Neogenex. Devices recorded under merged duplicate company entries are counted once.
Which registries list Neogenex's devices?
Among its 20 most recently registered devices, Neogenex has devices listed in FDA 510(k) (20 devices).
What risk classes do Neogenex's devices fall under?
Among its 20 most recently registered devices, the classes recorded for Neogenex's devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Neogenex in the registry?
The most recently registered devices listed for Neogenex include CHLAMYDIA TRACHOMATIS ANTIGEN TEST, RSV ANTIGEN TEST, INFLUENZA A ANTIGEN TEST and INFLUENZA B ANITGEN TEST.